Brief: SK Bioscience expands influenza vaccine exports to Southern Hemisphere markets
12/03/2025 14:02
March 12 (Reuters) - SK Bioscience Co Ltd 302440.KS: SK BIOSCIENCE EXPANDS INFLUENZA VACCINE EXPORTS TO SOUTHERN HEMISPHERE MARKET Source text: ID:nPn9Sjc07a Further company coverage: 302440.KS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on SK Bioscience Co
See all newsBrief: SK Bioscience Joins Forces With Global Institutions To Advance Rotavirus Vaccine Development
Brief: SK Bioscience Files For First-In-Human Trial Of Universal Coronavirus Vaccine GBP511 Phase 1/2 Study In Australia
Novavax beats quarterly revenue estimates on milestone payment (updated)
Brief: Sk Bioscience Submits Ind For Phase 1/2 Clinical Trial Of Adjuvanted Influenza Vaccine Candidate
Brief: SK Bioscience - Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine